ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.

ImmunityBio Inc Ordinary Shares -3.18%

ImmunityBio Inc Ordinary Shares

IBRX

5.79

-3.18%

ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via